Previous Article | Next Article ![]()
Infection and Immunity, April 2007, p. 2071-2074, Vol. 75, No. 4
0019-9567/07/$08.00+0 doi:10.1128/IAI.01785-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Centre for Infectious Disease, Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, Queen Mary, University of London, 4 Newark Street, London E1 2AT, United Kingdom,1 Clinical and Diagnostic Oral Sciences, Institute of Dentistry, Barts and The London School of Medicine and Dentistry, Queen Mary, University of London, 4 Newark Street, London E1 2AT, United Kingdom2
Received 9 November 2006/ Returned for modification 17 December 2006/ Accepted 21 January 2007
|
|
|---|
|
|
|---|
Genes were inactivated by insertion of the erm (ermF-ermAM) cassette from plasmid pVA2198, using an allele replacement strategy as described by Fletcher et al. (5). Briefly, the erm cassette (obtained by SacI plus PstI or SphI plus EcoRI digestion of pVA2198) was either inserted into the cloned genes (8) or ligated to PCR products to produce constructs in which the central region of each gene was replaced by the erm cassette. (PCR primers were as follows: for ragA, CGCTATTCTTCCTTTGCTTGCT and TTAC CATCCGCATCGACTTGA; for ragB, AATACTGAAAAT CCACGA and TAGGGGCTGCGACAAAAA; and for PG0183, GTGAACAAGCAGATTGGGG and CATAAGAGAGACGGAAACGAG). Prior to ligation with erm, the ragA product was digested with SacI plus PstI and the PG0183 product by SphI plus EcoRI. The DNA products were introduced into P. gingivalis by electroporation and transformants selected on media containing clindamycin, using methods described previously (16); replacement of the wild-type alleles was confirmed by demonstrating the expected length change for ragA or ragB by PCR and the expected restriction fragment changes by Southern blotting with ragA or ragB probes. In initial experiments, we were unsuccessful in the mutation of ragA or ragB in W50 but obtained mutants with mutations in both genes with the alternative rag-1 strain WPH35 (provided by W. P. Holbrook [12]). Subsequently, both ragA and PG0183 were successfully inactivated in strain W50; we were unsuccessful in inactivating ragB, but this was not pursued since the ragA mutant was phenotypically ragB negative. It is unclear why the two strains differed with respect to our ability to inactivate rag genes. The mutant alleles generated are illustrated in Fig. 1. The expression of RagA and RagB was examined in mutants by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (Fig. 2), with proteins prepared as described previously (4). A major 115-kDa outer membrane protein visible in both whole-cell and outer membrane protein profiles of W50 and WPH35 could not be detected after the disruption of ragA. The 55-kDa RagB protein was also absent in ragA mutants, as confirmed by Western blotting with the anti-RagB monoclonal antibody DRU55.5 (8, 12). (The same result as that shown in Fig. 2 was obtained for W50
ragA::erm [not shown].) Similarly, both RagA and RagB were absent in the WPH35 ragB mutant. We have previously demonstrated that ragA and ragB are cotranscribed (8); it is not known whether the loss of both proteins when either gene is disrupted is due to a requirement for both proteins in order to maintain a stable outer membrane protein complex or to a polar effect of insertion mutagenesis. Disruption of PG0183, a putative lipoprotein of unknown function encoded upstream of the rag locus, did not affect the expression of the Rag proteins.
![]() View larger version (10K): [in a new window] |
FIG. 1. Position of the erm (ermF-ermAM) cassette in P. gingivalis mutants. The upper line indicates the position of the rag operon and PG0183 in wild-type P. gingivalis W50 (8). Below are four mutant constructs in which the erm cassette is either inserted into, or replaces a section of, the corresponding genes of P. gingivalis W50 or WPH35. The positions of relevant restriction sites are shown.
|
![]() View larger version (15K): [in a new window] |
FIG. 2. Protein analysis of P. gingivalis W50 (lanes 1), WPH35 (lanes 2), WPH35 ragA::erm (lanes 3), and WPH35 ragB::erm (lanes 4), with molecular mass markers at 77, 66, 42, and 30 kDa (lanes M). (a) Whole-cell proteins stained with Coomassie blue; (b) outer membrane proteins stained with Coomassie blue; (c) Western blot of whole-cell proteins detected with ragB-specific monoclonal antibody DRU55.5 (12). Arrows labeled A and B mark the expected positions of RagA and RagB, respectively.
|
The virulence potential of the wild type and isogenic mutant strains of P. gingivalis was assessed in the murine model described by Kastelein et al. (10), by inoculation of bacteria at three different doses subcutaneously into the dorsolateral surfaces of eight mice per dosage group. A standardized protocol, approved by the local ethics committee and the United Kingdom Home Office animal experimentation licensing authority, was applied as described previously (3). Animals were scored twice daily on the basis of appearance, body weight, and lesion size, and moribund animals or those with a lesion size of greater than 15 mm in any direction were sacrificed and recorded as deaths. Figure 3 illustrates Kaplan-Meier survival curves for experiments with three different doses of the WPH35- and W50-derived strains, respectively (experiments were replicated in full for WPH35 strains and very similar results obtained [not illustrated]). All mice inoculated with 2 x 1010 or 1 x 1010 CFU of wild-type WPH35 (in both replications of the experiment) had died or been euthanized by 2.5 days (as shown in Fig. 3a). By contrast, all or seven of eight animals inoculated with the same inocula of WPH35 ragA::erm survived to the end of the study, though localized lesions, which resolved and healed, were observed. (In initial experiments, animals were followed for up to 15 days, but no further deaths occurred after 3 days, so later experiments were truncated after 4 days.) The ragB mutant of WPH35 appeared somewhat less attenuated, as the highest inoculum resulted in the death of the majority of mice; nevertheless, at the lower inocula, all mice receiving WPH35 ragB::erm survived. Similarly, all mice inoculated with wild-type W50 at all three dosages had died or been destroyed by 24 h, whereas with inocula of 1 x 1010 and 5 x 109 CFU per mouse of W50
ragA::erm, only one death occurred in each group within 24 h and the majority of animals survived (Fig. 3b). The highest inoculum of W50
ragA::erm resulted in the death of all eight mice within 48 h. In all experiments, the survival of both ragA mutant- and ragB mutant-inoculated mice was significantly greater (P < 0.01, log rank test, conducted with GraphPad Prism software) than that of mice inoculated with the isogenic wild-type strains at all bacterial loads tested. At the highest inoculum only, the survival of mice inoculated with WPH35 ragA::erm was significantly greater than that of those inoculated with WPH35 ragB::erm. A minority of animals inoculated with W50
PG0183::erm survived longer than those inoculated with wild-type W50, but the increased survival was not statistically significant in these experiments.
![]() View larger version (12K): [in a new window] |
FIG. 3. Kaplan-Meier survival curves for mice inoculated with wild-type and mutant P. gingivalis at different doses (numbers of CFU per mouse). (a and b) Two separate experiments. Eight mice were inoculated with each P. gingivalis strain at each dosage. In each experiment, all mice were inoculated on the same day with a single preparation of each strain, appropriately diluted.
|
We thank Jenny Slaney for her assistance with immunological techniques.
Published ahead of print on 5 February 2007. ![]()
# Present address: Beckman Coulter Inc., Mervue Industrial Estate, Galway, Ireland. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»